Cargando…

Sexual Dysfunction in Women Treated for Type 1 Diabetes and the Impact of Coexisting Thyroid Disease

INTRODUCTION: More sexual problems are reported among people treated for diabetes; however, this situation is less explored in women than in men. AIM: To analyze the presence and causal links of female sexual dysfunction (FSD) among Czech women treated for type 1 diabetes. METHODS: 40 women complete...

Descripción completa

Detalles Bibliográficos
Autores principales: Stechova, Katerina, Mastikova, Lenka, Urbaniec, Krzysztof, Vanis, Miroslav, Hylmarova, Simona, Kvapil, Milan, Pastor, Zlatko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523036/
https://www.ncbi.nlm.nih.gov/pubmed/30954495
http://dx.doi.org/10.1016/j.esxm.2019.03.001
_version_ 1783419240841216000
author Stechova, Katerina
Mastikova, Lenka
Urbaniec, Krzysztof
Vanis, Miroslav
Hylmarova, Simona
Kvapil, Milan
Pastor, Zlatko
author_facet Stechova, Katerina
Mastikova, Lenka
Urbaniec, Krzysztof
Vanis, Miroslav
Hylmarova, Simona
Kvapil, Milan
Pastor, Zlatko
author_sort Stechova, Katerina
collection PubMed
description INTRODUCTION: More sexual problems are reported among people treated for diabetes; however, this situation is less explored in women than in men. AIM: To analyze the presence and causal links of female sexual dysfunction (FSD) among Czech women treated for type 1 diabetes. METHODS: 40 women completed a national version of the Female Sexual Function Index (FSFI), Female Sexual Distress Scale-revised (FSDS-R), and Beck’s Depression Inventory–II (BDI-II). A metabolic and endocrine analysis was done using blood samples. Data were statistically analyzed using SPSS v.24 and the R environment. MAIN OUTCOME MEASURES: Patient details (personal information, diabetes-related data, and sex history), sexual performance (the FSFI and FSDS-R scores), and level of depression (the BDI-II score) were measured. RESULTS: FSD was present in 58% of the participants (based on the FSFI score), and 38% women declared significant sexual distress (according to their FSDS-R score). Even though only 4 women fulfilled the criteria for depression, we observed a strong association between BDI-II and FSFI (for total FSFI score P = .012, ρ = −0.394) resp. FSDS-R scores (P < .001, ρ = 0.552). Although we were not able to establish a clear direct connection between FSD and metabolic control, BDI-II scores were closely correlated with glycosylated hemoglobin (P = .009, ρ = 0.407). The duration of diabetes (based on FSDS-R: P = .046) but neither age nor the presence of chronic diabetic microvascular complications was associated with a higher FSD occurrence. We also observed an association between FSD and the presence of autoimmune hypothyroidism, even when successfully treated (FSDS-R: P = .009; FSFI: P = .067). CONCLUSION: FSD is more common in women with type 1 diabetes than in healthy women, and coexisting thyroid autoimmune disease seems to exacerbate FSD. Women suffering from type 1 diabetes, and particularly those with additional endocrinopathies, should be actively screened for FSD. Stechova K, Mastikova L, Urbaniec K, et al. Sexual Dysfunction in Women Treated for Type 1 Diabetes and the Impact of Coexisting Thyroid Disease. Sex Med 2019;7:217–226.
format Online
Article
Text
id pubmed-6523036
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-65230362019-05-24 Sexual Dysfunction in Women Treated for Type 1 Diabetes and the Impact of Coexisting Thyroid Disease Stechova, Katerina Mastikova, Lenka Urbaniec, Krzysztof Vanis, Miroslav Hylmarova, Simona Kvapil, Milan Pastor, Zlatko Sex Med Women's Sexual Health INTRODUCTION: More sexual problems are reported among people treated for diabetes; however, this situation is less explored in women than in men. AIM: To analyze the presence and causal links of female sexual dysfunction (FSD) among Czech women treated for type 1 diabetes. METHODS: 40 women completed a national version of the Female Sexual Function Index (FSFI), Female Sexual Distress Scale-revised (FSDS-R), and Beck’s Depression Inventory–II (BDI-II). A metabolic and endocrine analysis was done using blood samples. Data were statistically analyzed using SPSS v.24 and the R environment. MAIN OUTCOME MEASURES: Patient details (personal information, diabetes-related data, and sex history), sexual performance (the FSFI and FSDS-R scores), and level of depression (the BDI-II score) were measured. RESULTS: FSD was present in 58% of the participants (based on the FSFI score), and 38% women declared significant sexual distress (according to their FSDS-R score). Even though only 4 women fulfilled the criteria for depression, we observed a strong association between BDI-II and FSFI (for total FSFI score P = .012, ρ = −0.394) resp. FSDS-R scores (P < .001, ρ = 0.552). Although we were not able to establish a clear direct connection between FSD and metabolic control, BDI-II scores were closely correlated with glycosylated hemoglobin (P = .009, ρ = 0.407). The duration of diabetes (based on FSDS-R: P = .046) but neither age nor the presence of chronic diabetic microvascular complications was associated with a higher FSD occurrence. We also observed an association between FSD and the presence of autoimmune hypothyroidism, even when successfully treated (FSDS-R: P = .009; FSFI: P = .067). CONCLUSION: FSD is more common in women with type 1 diabetes than in healthy women, and coexisting thyroid autoimmune disease seems to exacerbate FSD. Women suffering from type 1 diabetes, and particularly those with additional endocrinopathies, should be actively screened for FSD. Stechova K, Mastikova L, Urbaniec K, et al. Sexual Dysfunction in Women Treated for Type 1 Diabetes and the Impact of Coexisting Thyroid Disease. Sex Med 2019;7:217–226. Elsevier 2019-04-04 /pmc/articles/PMC6523036/ /pubmed/30954495 http://dx.doi.org/10.1016/j.esxm.2019.03.001 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Women's Sexual Health
Stechova, Katerina
Mastikova, Lenka
Urbaniec, Krzysztof
Vanis, Miroslav
Hylmarova, Simona
Kvapil, Milan
Pastor, Zlatko
Sexual Dysfunction in Women Treated for Type 1 Diabetes and the Impact of Coexisting Thyroid Disease
title Sexual Dysfunction in Women Treated for Type 1 Diabetes and the Impact of Coexisting Thyroid Disease
title_full Sexual Dysfunction in Women Treated for Type 1 Diabetes and the Impact of Coexisting Thyroid Disease
title_fullStr Sexual Dysfunction in Women Treated for Type 1 Diabetes and the Impact of Coexisting Thyroid Disease
title_full_unstemmed Sexual Dysfunction in Women Treated for Type 1 Diabetes and the Impact of Coexisting Thyroid Disease
title_short Sexual Dysfunction in Women Treated for Type 1 Diabetes and the Impact of Coexisting Thyroid Disease
title_sort sexual dysfunction in women treated for type 1 diabetes and the impact of coexisting thyroid disease
topic Women's Sexual Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523036/
https://www.ncbi.nlm.nih.gov/pubmed/30954495
http://dx.doi.org/10.1016/j.esxm.2019.03.001
work_keys_str_mv AT stechovakaterina sexualdysfunctioninwomentreatedfortype1diabetesandtheimpactofcoexistingthyroiddisease
AT mastikovalenka sexualdysfunctioninwomentreatedfortype1diabetesandtheimpactofcoexistingthyroiddisease
AT urbanieckrzysztof sexualdysfunctioninwomentreatedfortype1diabetesandtheimpactofcoexistingthyroiddisease
AT vanismiroslav sexualdysfunctioninwomentreatedfortype1diabetesandtheimpactofcoexistingthyroiddisease
AT hylmarovasimona sexualdysfunctioninwomentreatedfortype1diabetesandtheimpactofcoexistingthyroiddisease
AT kvapilmilan sexualdysfunctioninwomentreatedfortype1diabetesandtheimpactofcoexistingthyroiddisease
AT pastorzlatko sexualdysfunctioninwomentreatedfortype1diabetesandtheimpactofcoexistingthyroiddisease